South Australian PrEPX study for those at risk for HIV infection
South Australians at a high risk of acquiring HIV will have the opportunity to enrol in a local Pre-Exposure Prophylaxis (PrEP*) research study which will be delivered through a partnership between Victoria’s Alfred Health, the South Australian Health and Medical Research Institute (SAHMRI), SA Health and clinics. SHINE SA will have a PrEP site at 57 Hyde Street.
500 people will be enrolled in the PrEPX-SA study from April 2017. People interested in participating can register online and those who are assessed as being at high risk will be enrolled. Communities most likely to benefit from PrEP include gay men, men who have sex with men (MSM), Aboriginal and Torres Strait Islander people, people from culturally and linguistically diverse backgrounds and partners of HIV-positive people.
SAMESH will be hosting a forum to provide information and answer questions about the PrEPX-SA study.
Date: Thursday 27 April
Time: 6pm – 7.30pm
Location: 57 Hyde Street, Adelaide
RSVP by: Monday 24 April, 5pm. There is limited capacity for this forum so please register early.
Full details of the PrEPX-SA study can be found at: www.alfredhealth.org.au/prepxsa
*PrEP is an antiretroviral medication taken daily by people at the highest risk of HIV to prevent them from acquiring HIV. PrEP has been shown internationally and nationally to reduce the number of new cases. There will be a co-payment for medication prescribed during the study.